ZYGMUNT PORADA JOINS EVOKE MEDICAL LEADERSHIP TEAM AS CEO

June 8, 2022, Evoke Medical, LLC announced today that Zygmunt Porada, MBA has joined its management team as CEO. Zyg will lead the equity investment efforts and refine the product strategy leveraging his customer facing background in cardiac pacing and biologics while continuing to expand the commercial, regulatory and clinical plans and activities.

​

Evoke Medical is developing the first ever patient powered smart implant with the ability to provide both mechanically synced electrical stimulation for enhanced bone healing as well as customized post-operative data analytics to optimize the patient’s treatment regimen as prescribed by the spinal surgeon.

Zyg has over 20 years of experience in the medical device industry, leading cross functional teams, accelerating new product launches and FDA approvals of class III products. His integrative approach between business, healthcare and technical stakeholders has successfully resulted in innovative products getting to market that improve patient’s quality of life and enhanced the standard of care.

“Zyg has been the perfect addition to our team both from a technical and business background perspective,” said Leighton LaPierre, Co-Founder and new COO.  “We can now focus on advancing the technology development and getting this to patients and their surgeons more effectively.”

​

Mr. Porada earned his MBA from Loyola University and a dual degree in Biomedical and Electrical Engineering from Johns Hopkins University.

​

"I am honored and excited to be joining Evoke Medical, as its new CEO. My focus is on cultivating a culture of collaboration, innovation, and accountability that will enable us to continue achieving impactful milestones," Zyg said. "I am committed to empowering the team and look forward to dramatically improving patient outcomes by leveraging this novel technology platform to bring innovative spinal and orthopedic products to market."